New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
09:59 EDTTHR, GNW, MIND, ESV, PAY, KMB, DTV, DB, AZN, ATK, CHA, ARCP, CTL, MOOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ATK (ATK) downgraded to Neutral from Buy at Goldman... Altria Group (MO) downgraded to Market Perform from Outperform at Wells Fargo... American Realty (ARCP) downgraded to Neutral from Outperform at RW Baird... AstraZeneca (AZN) downgraded to Market Perform from Outperform at Leerink... CenturyLink (CTL) downgraded to Equal Weight from Overweight at Morgan Stanley... China Telecom (CHA) downgraded to Neutral from Buy at Goldman... Deutsche Bank (DB) downgraded to Underperform from Neutral at BofA/Merrill... DirecTV (DTV) downgraded to Hold from Buy at Wunderlich... Ensco (ESV) downgraded to Hold from Buy at Jefferies... Genworth (GNW) downgraded to Underweight from Equal Weight at Morgan Stanley... Kimberly Clark (KMB) downgraded to Hold from Buy at Argus... Mitcham Industries (MIND) downgraded to Accumulate from Buy at Global Hunter... Thermon Group (THR) downgraded to Hold from Buy at KeyBanc... VeriFone (PAY) downgraded to Neutral from Positive at Susquehanna.
News For ATK;MO;ARCP;AZN;CTL;CHA;DB;DTV;ESV;GNW;KMB;MIND;THR;PAY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 20, 2015
08:43 EDTCHANomura to hold a conference
Subscribe for More Information
May 19, 2015
15:05 EDTAZNArdelyx scheduled for end Phase 2 meeting with FDA scheduled in June
Subscribe for More Information
06:15 EDTDBDeutsche Bank explores moving parts if UK leaves EU, Financial Times says
Subscribe for More Information
May 18, 2015
19:20 EDTDBDeutsche Bank retail chief to quit after disagreement, Reuters says
Rainer Neske, Deutsche Bank's head of retail banking, is set to resign because he disagrees with the company's restructuring program, reports Reuters, citing unnamed industry sources quoted by Handelsblatt. Reuters notes that the restructuring involves selling the Postbank retail business, increasing investments in equities and wealth management, and divesting up to $169.65B in investment bank assets. Reference Link
13:48 EDTESVEnsco reports departure of chairman Dan Rabun
Subscribe for More Information
08:59 EDTDTVAT&T CEO says gets profitable TV product from 'day one' by buying DirecTV
AT&T (T) CEO Randall Stephenson said AT&T's existing U-verse product is "nice" but unprofitable and that the company will get a profitable TV product from "day one" by buying DireTV (DTV). Stephenson said he expects to take share from cable operators and other TV offerings with its combined offering after the DirecTV deal closes. Stephenson said the company is on target to get the DirecTV deal closed in Q2. Stephenson spoke on CNBC.
08:45 EDTDTVCogent CEO says considering lawsuit against AT&T, CTFinancialNews reports
Subscribe for More Information
06:58 EDTDBDeutsche Bank co-CEOs won't step down, Reuters reports
Subscribe for More Information
06:13 EDTAZNAstraZeneca to invest $285M in new biologics manufacturing facility in Sweden
AstraZeneca announced that it plans to invest approximately $285M in a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The new plant will be focused on filling and packaging of protein therapeutics. It is anticipated that the new facility will supply medicines for clinical trial programs of AstraZeneca and MedImmune, the company’s global biologics research and development arm, from the end of 2018, and will deliver finished products for commercial use once fully operational by 2019. Södertälje is currently home to AstraZeneca’s largest global tablets and capsules manufacturing facility and is also a launch platform site for the company, with specialist capabilities on-site that allow large-scale production of new medicines, working closely with the research and development organisation. By locating the new manufacturing plant in Södertälje, the company will combine its expertise in biologics with the well-established culture of operational excellence that exists within the Sweden Operations unit. The planned investment will, subject to relevant approvals by the local authorities, create between 150 and 250 highly skilled new roles at AstraZeneca by 2019. The new manufacturing facility in Sweden will support the progression of drug candidates across the main therapy areas and be aligned with investments being made in the current biologics manufacturing centers, such as the expansion in Frederick, Maryland, announced in November.
May 17, 2015
15:49 EDTAZNAstraZeneca reports Movantik shows 'similar' adverse event rate vs. placebo
Subscribe for More Information
May 15, 2015
16:28 EDTARCPAppaloosa Management gives quarterly update on stakes
Subscribe for More Information
09:31 EDTAZNAmerican Thoracic Society to hold a conference
ATS 2015 Conference is being held in Denver on May 15-20.
May 14, 2015
10:37 EDTDTVDISH CEO says AT&T, DirecTV merger will bring tougher competitor
Subscribe for More Information
09:22 EDTAZNLeerink pharma/biotech analysts hold an analyst/industry conference call
Subscribe for More Information
06:37 EDTDTVDISH, Cogent ask FCC to set conditions for AT&T acquisition, Reuters says
DISH (DISH) and Cogent Communications (CCOI) asked the FCC to force AT&T (T) to sell Internet service as a standalone service, as a condition of the telecom giant's proposed acquisition of DirecTV (DTV), according to Reuters. DISH and Cogent also asked the agency to make AT&T sell standalone Internet service at a reasonable price and at the same speeds it provides in package deals, the news service stated. Reference Link
06:04 EDTDBUnivision IPO could launch 'in weeks,' NY Post reports
Subscribe for More Information
05:52 EDTAZNMizuho expects CAR T stocks to be volatile after ASCO abstract
Subscribe for More Information
May 13, 2015
17:24 EDTAZNAstraZeneca to update progress with immuno-oncology pipeline at ASCO
AstraZeneca and MedImmune, the company’s global biologics research and development arm, will demonstrate rapid progress with their combination-focused oncology pipeline at the American Society of Clinical Oncology, or ASCO, Annual Meeting, May 29-June 2. 61 scientific abstracts will be presented at the meeting, reinforcing the significant progress in immuno-oncology through combination therapies and innovative companion diagnostics.
10:01 EDTKMBOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:32 EDTKMBKimberly-Clark upgraded to Overweight from Equal Weight at Barclays
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use